We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$36.2B
AUM Growth
+$2.03B
Cap. Flow
-$1.03B
Cap. Flow %
-2.85%
Top 10 Hldgs %
14.34%
Holding
2,349
New
214
Increased
749
Reduced
1,086
Closed
196

Sector Composition

Rank Sector Weight
1 Healthcare 22.91%
2 Financials 14.92%
3 Technology 12.39%
4 Consumer Discretionary 8.32%
5 Consumer Staples 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMI icon
1551
Kinder Morgan
KMI
$68.4B
$205K ﹤0.01%
11,355
-7,118
-39% -$128K
CHGG icon
1552
Chegg
CHGG
$81.5M
$204K ﹤0.01%
8,065
-2,245,827
-100% -$57.1M
KD icon
1553
Kyndryl
KD
$2.8B
$203K ﹤0.01%
18,244
+1,013
+6% +$10.2K
NVAX icon
1554
Novavax
NVAX
$1.54B
$200K ﹤0.01%
19,449
+15,183
+356% +$268K
BSRR icon
1555
Sierra Bancorp
BSRR
$526M
$199K ﹤0.01%
9,372
+13
+0.1% +$279
AMH icon
1556
American Homes 4 Rent
AMH
$11.3B
$199K ﹤0.01%
6,600
VRSN icon
1557
VeriSign
VRSN
$27B
$198K ﹤0.01%
963
-73
-7% -$14K
MIRM icon
1558
Mirum Pharmaceuticals
MIRM
$6.32B
$195K ﹤0.01%
10,000
+9,985
+66,567% +$197K
VSAT icon
1559
Viasat
VSAT
$9.77B
$194K ﹤0.01%
6,131
-1,647
-21% -$57.6K
SHO icon
1560
Sunstone Hotel Investors
SHO
$2.05B
$193K ﹤0.01%
+20,000
New +$207K
INVE icon
1561
Identive
INVE
$62M
$192K ﹤0.01%
+26,563
New +$257K
FORM icon
1562
FormFactor
FORM
$8.19B
$191K ﹤0.01%
+8,594
New +$200K
WHWK
1563
Whitehawk Therapeutics
WHWK
$230M
$191K ﹤0.01%
+14,870
New +$194K
PRVB
1564
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$189K ﹤0.01%
+17,847
New +$144K
OKUR
1565
OnKure Therapeutics
OKUR
$117M
$186K ﹤0.01%
8,000
+5,000
+167% +$133K
NIC icon
1566
Nicolet Bankshares
NIC
$3.52B
$185K ﹤0.01%
2,315
+1
+0% +$78
SNOW icon
1567
Snowflake
SNOW
$117B
$182K ﹤0.01%
1,271
+130
+11% +$19.8K
BKR icon
1568
Baker Hughes
BKR
$55.9B
$182K ﹤0.01%
6,169
-1,223
-17% -$33.7K
LDOS icon
1569
Leidos
LDOS
$16.2B
$181K ﹤0.01%
1,719
-606
-26% -$62K
EFSC icon
1570
Enterprise Financial Services Corp
EFSC
$2.25B
$181K ﹤0.01%
3,689
-584
-14% -$29K
RCKT icon
1571
Rocket Pharmaceuticals
RCKT
$382M
$179K ﹤0.01%
9,154
+2,333
+34% +$43K
PCAR icon
1572
PACCAR
PCAR
$62.2B
$177K ﹤0.01%
2,679
-597
-18% -$39K
NPKI
1573
NPK International
NPKI
$1.1B
$171K ﹤0.01%
41,315
-149,474
-78% -$548K
GLNG icon
1574
Golar LNG
GLNG
$5.14B
$171K ﹤0.01%
+7,500
New +$188K
III icon
1575
Information Services Group
III
$255M
$169K ﹤0.01%
36,660
+25,055
+216% +$127K

Similar funds

Federated Hermes's Q4 2022 Portfolio in Review

As of Q4 2022, Federated Hermes held 2,349 positions worth $36.2B, up 6% from $34.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Federated Hermes's Q4 2022 filing shows 214 new, 749 increased, 1,086 reduced and 196 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M. The largest sale was Amgen, an estimated $211M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.

  • Federated Hermes's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M.
  • Federated Hermes added most to LyondellBasell Industries in Q4 2022, an estimated $165M increase.
  • Federated Hermes's biggest Q4 2022 reduction was Amgen, cutting an estimated $211M.
  • Federated Hermes fully exited Akouos Inc in Q4 2022, selling an estimated $27M.
  • Federated Hermes's ten largest holdings make up 14% of its $36.2B portfolio in Q4 2022.
  • Federated Hermes opened 214 new positions and closed 196 in Q4 2022.
  • Federated Hermes's portfolio value rose 6% quarter-over-quarter to $36.2B.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.